We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
Publications
Search our publications, laboratory reports, meeting statements, scheduling submissions and scheduling decisions.
Can't find what you’re looking for? You can also:
- search our Resources
- use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Committees and advisory bodies (376)
- Scheduling (national classification system) (174)
- Safety monitoring and information (31)
- COVID-19 (11)
- Manufacturing (11)
- Advertising (9)
- Clinical trials (6)
- Medicinal cannabis hub (6)
- Compliance and enforcement (5)
- Sunscreens (5)
- Fees and payments (4)
- Shortages and supply disruptions (4)
- Legislation (3)
- Breast implant hub (1)
- Import and export (1)
- Labelling and packaging (1)
- Metal-on-metal hip replacement implants hub (1)
- Prescription opioids hub (1)
- Unique Device Identification (UDI) hub (1)
Search
764 result(s) found, displaying 501 to 525
-
Meeting statementsAdvisory Committee on Medical Devices (ACMD) meeting 45 statement.
-
Meeting statementsAdvisory Committee on Medical Devices meeting statement.
-
Meeting statementsAdvisory Committee on Medical Devices (ACMD) meeting statement.
-
Meeting statementsAdvisory Committee on Medical Devices (ACMD) meeting 48 statement.
-
Scheduling submissionsOutcomes of the public consultation on Appendix M of the Poisons Standard are now available
-
-
Meeting statementsAdvisory Committee on Vaccines meeting statement is now available
-
Scheduling decisions (final)Final decision on the scheduling of alkyl nitrites - a matter which was most recently referred to the March 2019 Joint Advisory Committees on Medicines and Chemicals Scheduling (Joint ACMS-ACCS#21).
-
Scheduling decisions (interim)Interim decisions and invitation for further comment. Closing date: 4 July 2019
-
Corporate reportsAbout the 2018 consultation: Regulatory options for appropriate access and safety controls for alkyl nitrites
-
TGA laboratory testing reportsTGA Laboratories has released a report detailing testing of alkyl nitrite products
-
Scheduling decisions (final)Delegate-only scheduling final decisions are now available
-
Scheduling submissionsPublic submissions on scheduling matters referred to ACMS/ACCS meetings held in November 2018
-
Scheduling decisions (final)Final decisions and reasons for NCEs and medicines and chemicals referred to the November 2018 scheduling meetings (ACMS #25, ACCS #23 and Joint ACMS-ACCS #20).
-
Meeting statementsAdvisory Committee on Complementary Medicines meeting statement for 28 March 2019
-
Meeting statementsAdvisory Committee on Vaccines meeting statement is now available
-
Meeting statementsThe Public Statement for the Generic Medicines Working Group face-to-face meeting in Canberra, October 2018
-
Corporate reportsThe Action Plan will further improve Australia’s medical device regulatory system and place patient safety first
-
Corporate reportsThe 2018 Half Yearly Performance Snapshot is now available
-
Meeting statementsPublic statement for the Generic Medicines Working Group face-to-face meeting in Switzerland, May 2018
-
Corporate reportsStatistics from inspections conducted from 1 September 2017 to 31 December 2018
-
Meeting statementsCommunique summarising outcomes of the alkyl nitrites public meetings in Sydney and Melbourne
-
Meeting statementsAdvisory Committee on Vaccines meeting statement is now available
-
TGA laboratory testing reportsThe TGA has tested a range of human insulin products and all met the applicable quality standards
-
Corporate reportsInformation about new Scheduling Policy Framework (SPF) and Scheduling Handbook following extensive stakeholder, and in collaboration with State and Territory departments